Management of distal ulcerative colitis: frequently asked questions analysis. - Test2 - elhamkhani - TriplyDB

Management of distal ulcerative colitis: frequently asked questions analysis.

Management of distal ulcerative colitis: frequently asked questions analysis.

http://www.wikidata.org/entity/Q37091094

about

A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.Pros and cons of medical management of ulcerative colitis.Efficacy and safety of drugs for ulcerative colitis.A case of lower digestive tract hemorrhage caused by appendicitis in China Topical therapy is underused in patients with ulcerative colitis.Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study.Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid.Ulcerative colitis with Guillain-Barré syndrome: A case report.

P2860

Q34533594-B2E85480-6FBC-4959-84E3-9A52EE30ABF2 Q35100726-513AB15E-57FB-4839-9FA1-73B885DDAB52 Q37727232-793927DB-5A7D-4FB0-927C-C34C7F37C867 Q41302638-517978AD-DE37-44D3-9AA4-1D9691620657 Q44237715-A69E28CE-656E-4636-83FF-1CB1830BD5AC Q47583468-DB917697-E5FA-4F57-8A15-82FA03337D0C Q52864255-D738A6D2-1C04-4B29-89A5-BB09DC83A58E Q55492261-9B297365-043C-47BC-B44D-409151A0D0C3

P2860

Management of distal ulcerative colitis: frequently asked questions analysis.

http://www.wikidata.org/entity/Q37091094

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Management of distal ulcerative colitis: frequently asked questions analysis.

@en

Management of distal ulcerative colitis: frequently asked questions analysis.

@nl

type

label

Management of distal ulcerative colitis: frequently asked questions analysis.

@en

Management of distal ulcerative colitis: frequently asked questions analysis.

@nl

prefLabel

Management of distal ulcerative colitis: frequently asked questions analysis.

@en

Management of distal ulcerative colitis: frequently asked questions analysis.

@nl

P1433

Q37091094-A3A0F4CA-A06A-44CA-9351-DFB3E2B9DBFF

P1476

Q37091094-37ED4740-12CA-436F-BB14-D19BA652F3DA

P2093

Q37091094-00D949C1-447D-42B6-B091-60947166A1E7

Q37091094-872D79AA-E5AC-4598-A64F-3C785497EE22

Q37091094-A436A422-6DDD-447F-9099-17E36625C470

P2860

Q37091094-054FF3EE-421A-42C0-A613-7EFE52EFAD3A

Q37091094-2AF11059-674D-4B5E-A3AE-7AD26AE73F89

Q37091094-507136E4-C324-444A-917C-8EC02C135CB0

Q37091094-58F3478F-6386-4E04-AFC9-10D7D7FBF295

Q37091094-5BE22400-036B-4E2C-930A-77BDF84EA138

Q37091094-6A403C47-CA55-4579-88EB-488EB7D69F6E

Q37091094-70E5E207-E094-4F79-BFDF-4ED6CBE4155C

Q37091094-7E0A6BDC-0BEF-4F1F-AD5F-DD48E11C51F4

Q37091094-8CE0F0EB-B4E4-40A2-AB9E-E792B6F4AC86

Q37091094-8DAF3669-6BC4-441A-94F9-0402C8F5FFE1

P304

Q37091094-275C3A82-A3EE-4BE6-B131-FD2E3A2631E7

P31

Q37091094-3D2275E0-70A3-4923-9296-49DC21A7B192

P356

Q37091094-2C1DF4DC-F9E3-4CC9-93C9-2A328B931C21

P433

Q37091094-D162A9D0-D650-482A-BD4D-4ECA8C253E42

P478

Q37091094-1F15377D-2308-4DC7-8833-F28308885106

P50

Q37091094-773F628E-3762-4163-A216-F970E05A27EB

P577

Q37091094-1BB48789-2F51-4FC3-AF51-E687B15958F6

P698

Q37091094-AFECACFA-D652-454B-AEB9-5A5D39643A5F

P356

J.1445-5994.2007.01601.X

P1433

Internal Medicine Journal

P1476

Management of distal ulcerative colitis: frequently asked questions analysis

@en

P2093

P M Irving

http://www.w3.org/2001/XMLSchema#string

P R Gibson

http://www.w3.org/2001/XMLSchema#string

S L James

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

Review article: maintenance therapy in patients with ulcerative colitis

Infliximab for induction and maintenance therapy for ulcerative colitis

Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Iron, anaemia, and inflammatory bowel diseases.

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.

Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.

P304

114-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-5994.2007.01601.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Richard B. Gearry

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18290827

http://www.w3.org/2001/XMLSchema#string